Medable

Medable is a leader in the digital clinical trial space, offering a comprehensive platform that integrates agentic AI, eCOA, and DCT capabilities to modernize and accelerate drug development. Founded in 2014 and headquartered in Palo Alto, the company serves a prestigious client base, including 14 of the top 20 pharmaceutical companies, and boasts significant efficiency claims such as building studies 35x faster. Its recent focus on launching 'Agent Studio,' an industry-first agentic AI platform, positions it at the forefront of automating complex, manual processes in clinical operations to drive ROI and reduce trial 'white space.'

Unified clinical trial platform featuring Agentic AI (Agent Studio), electronic Clinical Outcome Assessment (eCOA), and Decentralized Clinical Trial (DCT) solutions. Built on a cloud-agnostic, single API architecture for global scalability.

Medable competes in a crowded market including large, established players like Veeva Systems (Veeva Vault eClinical) and Dassault Systèmes (Medidata), as well as numerous specialized eCOA and DCT providers. Its key differentiators are its focused agentic AI platform (Agent Studio), a unified architecture, and strong recognition for patient-centric eCOA design.